Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Mechanisms of statin-induced myalgia assessed by physiogenomic associations.

Ruaño G, Windemuth A, Wu AH, Kane JP, Malloy MJ, Pullinger CR, Kocherla M, Bogaard K, Gordon BR, Holford TR, Gupta A, Seip RL, Thompson PD.

Atherosclerosis. 2011 Oct;218(2):451-6. doi: 10.1016/j.atherosclerosis.2011.07.007. Epub 2011 Jul 20.

2.

Statin myotoxicity: a review of genetic susceptibility factors.

Needham M, Mastaglia FL.

Neuromuscul Disord. 2014 Jan;24(1):4-15. doi: 10.1016/j.nmd.2013.09.011. Epub 2013 Sep 30. Review.

PMID:
24176465
3.

Clinical and laboratory phenotype of patients experiencing statin intolerance attributable to myalgia.

Harris LJ, Thapa R, Brown M, Pabbathi S, Childress RD, Heimberg M, Braden R, Elam MB.

J Clin Lipidol. 2011 Jul-Aug;5(4):299-307. doi: 10.1016/j.jacl.2011.05.005. Epub 2011 Jun 12.

PMID:
21784376
4.

Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?

Ruaño G, Thompson PD, Kane JP, Pullinger CR, Windemuth A, Seip RL, Kocherla M, Holford TR, Wu AH.

Pharmacogenomics. 2010 Jul;11(7):959-71. doi: 10.2217/pgs.10.58.

5.

Physiogenomic association of statin-related myalgia to serotonin receptors.

Ruaño G, Thompson PD, Windemuth A, Seip RL, Dande A, Sorokin A, Kocherla M, Smith A, Holford TR, Wu AH.

Muscle Nerve. 2007 Sep;36(3):329-35.

PMID:
17600820
6.

Risk identification and possible countermeasures for muscle adverse effects during statin therapy.

Magni P, Macchi C, Morlotti B, Sirtori CR, Ruscica M.

Eur J Intern Med. 2015 Mar;26(2):82-8. doi: 10.1016/j.ejim.2015.01.002. Epub 2015 Jan 29. Review.

PMID:
25640999
7.

Patients experiencing statin-induced myalgia exhibit a unique program of skeletal muscle gene expression following statin re-challenge.

Elam MB, Majumdar G, Mozhui K, Gerling IC, Vera SR, Fish-Trotter H, Williams RW, Childress RD, Raghow R.

PLoS One. 2017 Aug 3;12(8):e0181308. doi: 10.1371/journal.pone.0181308. eCollection 2017.

8.

Changes in muscle strength in individuals with statin-induced myopathy: A summary of 3 investigations.

Panza GA, Taylor BA, Dada MR, Thompson PD.

J Clin Lipidol. 2015 May-Jun;9(3):351-6. doi: 10.1016/j.jacl.2015.01.004. Epub 2015 Jan 28.

PMID:
26073393
9.

The genetics of statin-induced myopathy.

Ghatak A, Faheem O, Thompson PD.

Atherosclerosis. 2010 Jun;210(2):337-43. doi: 10.1016/j.atherosclerosis.2009.11.033. Epub 2009 Nov 27. Review.

PMID:
20042189
10.

Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia.

Young JM, Florkowski CM, Molyneux SL, McEwan RG, Frampton CM, George PM, Scott RS.

Am J Cardiol. 2007 Nov 1;100(9):1400-3. Epub 2007 Aug 16.

PMID:
17950797
12.

Muscle-related side-effects of statins: from mechanisms to evidence-based solutions.

Taylor BA, Thompson PD.

Curr Opin Lipidol. 2015 Jun;26(3):221-7. doi: 10.1097/MOL.0000000000000174. Review.

PMID:
25943841
13.

A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy.

Taylor BA, Lorson L, White CM, Thompson PD.

Atherosclerosis. 2015 Feb;238(2):329-35. doi: 10.1016/j.atherosclerosis.2014.12.016. Epub 2014 Dec 17.

14.

Vitamin D deficiency, myositis-myalgia, and reversible statin intolerance.

Glueck CJ, Budhani SB, Masineni SS, Abuchaibe C, Khan N, Wang P, Goldenberg N.

Curr Med Res Opin. 2011 Sep;27(9):1683-90. doi: 10.1185/03007995.2011.598144. Epub 2011 Jul 6.

PMID:
21728907
15.

Coenzyme Q(10) and statin myalgia: what is the evidence?

Mas E, Mori TA.

Curr Atheroscler Rep. 2010 Nov;12(6):407-13. doi: 10.1007/s11883-010-0134-3.

PMID:
20725809
16.

Managing statin-induced muscle toxicity in a lipid clinic.

Blaier O, Lishner M, Elis A.

J Clin Pharm Ther. 2011 Jun;36(3):336-41. doi: 10.1111/j.1365-2710.2011.01254.x. Epub 2011 Mar 18.

PMID:
21414023
17.

Physiogenomic analysis links serum creatine kinase activities during statin therapy to vascular smooth muscle homeostasis.

Ruaño G, Thompson PD, Windemuth A, Smith A, Kocherla M, Holford TR, Seip R, Wu AH.

Pharmacogenomics. 2005 Dec;6(8):865-72.

PMID:
16296949
18.

Coenzyme Q10 supplementation decreases statin-related mild-to-moderate muscle symptoms: a randomized clinical study.

Skarlovnik A, Janić M, Lunder M, Turk M, Šabovič M.

Med Sci Monit. 2014 Nov 6;20:2183-8. doi: 10.12659/MSM.890777.

19.

Coenzyme Q10: a therapy for hypertension and statin-induced myalgia?

Wyman M, Leonard M, Morledge T.

Cleve Clin J Med. 2010 Jul;77(7):435-42. doi: 10.3949/ccjm.77a.09078. Review.

PMID:
20601617
20.

Low plasma vitamin D levels and muscle-related adverse effects in statin users.

Eisen A, Lev E, Iakobishvilli Z, Porter A, Brosh D, Hasdai D, Mager A.

Isr Med Assoc J. 2014 Jan;16(1):42-5.

Supplemental Content

Support Center